We have investigated the ability of dsRNA to inhibit gene functions in zebrafish using sequences targeted to the maternal gene pouII-1, the transgene GFP, and an intron of the zebrafish gene terra. We found that embryos injected with all of these dsRNAs at approximately 7.5 pg/embryo or higher had general growth arrest during gastrulation and displayed various nonspecific defects at 24 h postfertilization, although embryonic development was unaffected before the midblastula stage. Reducing dsRNA concentration could alleviate the global defects. Injection of GFP dsRNA (7.5-30 pg/embryo) did not inhibit GFP expression in transgenic fish, although abnormal embryos were induced. Co-injection of GFP mRNA with either GFP or non-GFP dsRNA caused reduction of GFP expression. Whole-mount in situ hybridization clearly showed that embryos injected with dsRNA degraded co-injected and endogenous mRNA without sequence specificity, indicating that dsRNA has a nonspecific effect at the posttranscriptional level. It appears that RNAi is not a viable technique for studying gene function in zebrafish embryos.
INTRODUCTION
first reported that introduction of dsRNA molecules into Caenorhabditis elegans can specifically inhibit the activity of genes containing homologous sequences. This effect of dsRNA, called RNA interference or RNAi, happens at a posttranscriptional level at which endogenous mRNA is targeted to degrade . Since then, RNAi studies have been reported in other species, including Drosophila melanogaster (Knnerdell and Carthew, 1998; Misquitta and Paterson, 1999) , trypanosomes (Ngo et al., 1998) , planaria (SanchezAlvarado and Newmark, 1999) , hydra (Lohmann et al., 1999) , mouse (Wianny and Zernicka-Goetz, 2000) , and zebrafish (Wargelius et al., 1999; Li et al., 2000) . In plants, simultaneous expression of sense and antisense RNA from transgenes, which allows RNA duplex formation, specifically silences the transgenes at the posttranscriptional level on the transformed plants (Vaucheret et al., 1998; Waterhouse et al., 1998) . Tuschl et al. (1999) developed a cell-free system from syncytial blastoderm embryos of Drosophila and showed that in such an in vitro system incubation of dsRNA causes rapid decay of homologous target mRNA. Thus, RNA interference can be a powerful tool for studying gene functions by inducing loss-of-function phenotypes.
In zebrafish, Wargelius et al. (1999) first reported that embryos injected with no tail or lacZ dsRNA showed a reduced level of the endogenous mRNA and 20 -30% of the embryos displayed specific defects reflective of no tail phenotypes. The authors also described that approximately equivalent numbers of the injected embryos had some general defects. Furthermore, the amounts of dsRNA required for induction of specific defects in zebrafish were approximately 60 pg per embryo (pg/e), over 100 times higher than in Drosophila. A significantly different result was reported by Li et al. (2000) , who claimed that more than 80% of the embryos injected with the same amount of dsRNA produced specific defects. They did not report any toxicity in their studies, establishing RNAi as an ideal approach for sequence-specific gene inactivation in zebrafish. More recently, Oates et al. (2000) demonstrated that injection of dsRNAs, regardless of origin, induces degradation of mRNAs transcribed from zygotic genes and causes various embryonic abnormalities at 12 and 24 h postfertilization. Consistent with Oates' findings, our studies also indicate that RNAi has a nonspecific interference effect in zebrafish. We feel that our data should also be made available to the community and that the technique needs to be further developed.
MATERIALS AND METHODS

Plasmids Used for RNA Synthesis
Zebrafish pouII-1 is a maternally expressed POU family gene that we identified recently (our unpublished data). Two fragments produced by XhoI/EcoRI digestion of plasmid pZfpouII-1, which contains full-length cDNA of pouII-1, were subcloned into pBluescript II KS(Ϫ) to generate pZfpouII-1/5Ј and pZfpouII-1/3Ј. Plamid pZfpouII-1/5Ј contains the first 640 bp of the pouII-1 gene, while pZfpouII-1/3Ј contains the remaining part of the gene, including a region encoding almost the whole POU domain. pZfpouII-1/5Ј was used to make pouII-1 dsRNA and pZfpouII-1/3Ј to generate digoxigenin-labeled RNA probes for whole-mount in situ hybridization.
The GFP coding sequence, derived from GM2 , was cloned in pBluescript II KS(Ϫ) to give plasmid pGFP/ϪA. This construct contains no poly(A) signal and is used for generating GFP dsRNA and digoxigenin-labeled RNA probes for whole-mount in situ hybridization. Another construct, pKS-GM2, was generated by cloning GFP coding sequence plus a SV40 polyadenylation signal into pBluescript II KS(Ϫ), which was used for producing GFP mRNA.
The third intron of zebrafish terra (Meng et al., 1999) was amplified by PCR using a template from DNA of a terra-containing PAC clone, and a 650-bp product was cloned into pBluescript KS(Ϫ). This recombinant plasmid was used to make intronT dsRNA.
Synthesis of RNA
All the plasmids were linearized with an appropriate restriction enzyme and purified with GeneClean III Kit (Bio 101, Inc.) prior to in vitro transcription. Sense and antisense RNAs were synthesized using T3 or T7 RiboMAX Large Scale RNA Production Systems (Promega). After a transcription reaction was done, the reaction mixture was treated with DNase I to remove the DNA template. Then, the mixture was extracted once with phenol/chloroform and once with chloroform, and RNA was precipitated with isopropanol and dissolved in RNase-free water. For making dsRNA, equal amounts of newly synthesized sense and antisense RNAs were mixed with addition of the annealing buffer stock to final concentrations of 1.5 M sodium chloride and 0.667 M sodium bicarbonate. The mixture was sequentially incubated at 100°C for 10 min, at 55°C for 2 h, and at 37°C overnight. The annealed RNA (dsRNA) was treated with RNase One (Promega) to degrade single-stranded RNA. Then, it was extracted with organic solvents, precipitated with ethanol, and dissolved in 5 mM Tris, 0.5 mM EDTA, pH 7.0. Different RNA species were checked on agarose gels (see Fig. 1 for an example).
RNase One-treated single-stranded RNA, dsRNA without RNase One treatment, and RNase One-treated or untreated DNA were also used for injection to test whether RNase One contamination in the preparations potentially produced toxicity syndromes.
For synthesis of GFP mRNA, the transcription mixture contained a final concentration of 5 mM cap analog (Promega) so that the newly synthesized RNA had a cap structure that was required for efficient translation in eukaryotic cells.
Injection of RNA
Single-stranded or double-stranded RNA was injected into the cytoplasm of 1-cell embryos. To avoid potential damage of dechorionation with proteinase to embryos, injection was performed using fertilized eggs with a chorion. Prior to injection, RNAs were diluted to a desired concentration and KCl was added to a final concentration of 0.1 M. Each microliter of RNA solution was used to inject about 400 eggs. The dose of RNA injection was converted to picograms per embryo. Injection with each type of RNA was performed at least three times. To facilitate calculating mortality of the injected embryos, unfertilized eggs were removed at the 32-cell stage, about 2 h after laying, and the remaining embryos were observed later under a dissection microscope at various developmental stages.
For co-injection of GFP mRNA and dsRNA, the fertilized eggs were injected first with GFP mRNA, and then half of them were injected again with dsRNA before proceeding to the two-cell stage. The injection dose for GFP mRNA was fixed at 150 pg/e and that for dsRNA was variable (see text). The injected embryos were observed for GFP by fluorescence microscopy using a GFP filter (Leica).
Unless otherwise stated in the following sections, eggs from wild-type zebrafish were used for injection. Transgenic fish used in this experiment were generated with a transgene consisting of the zebrafish GATA-1 promoter and GFP gene (Long et al., 1997) . The GFP expression in these transgenic fish is restricted to hematopoietic tissues and some neuronal cells.
Whole-Mount in Situ Hybridization
Sense and antisense RNA probes of GFP cDNA and the 3Ј part of pouII-1 were generated by in vitro transcription in the presence of digoxigenin-UTP. The sense RNA probe was used as a negative
FIG. 1.
Gel analysis of GFP RNAs. Lanes 1 and 3, sense RNA before and after RNase One treatment; lanes 2 and 4, antisense RNA before and after RNase One treatment; lanes 5 and 6, dsRNA before and after RNase One treatment; lane 7, 100 bp markers with a brighter band at 600 bp.
FIG. 2.
Effect of dsRNA injection on survival rate of embryos. Zebrafish fertilized eggs were injected with 150 pg/e of different RNAs and DNA. (A) The percentages of surviving embryos at different stages of the total number of fertilized embryos counted at the 32-cell stage (in parentheses) were calculated. For each gene, three types of RNAs, i.e., dsRNA, sense (sϪ), and antisense (aϪ) RNAs, were injected. Only dsRNAs were treated with RNase One before injection. (B) dsRNA and DNA of pouII-1 treated (RNaseϩ) or untreated (RNaseϪ) with RNase One, and RNase-treated pouII-1 sense RNA were injected in parallel. The percentages of normal surviving embryos at 24 hpf of the total number of fertilized embryos counted at the 32-cell stage (in parentheses) are shown. Data shown in (A) and (B) were obtained from two independent experiments. control. The injected embryos were fixed in 4% paraformaldhyde and used for in situ hybridization essentially following the protocol described by Westerfield (1995) .
RESULTS AND DISCUSSION
RNAi Causes Nonspecific Abnormal Development of Zebrafish Embryos
We planned to study the function of a novel POU gene identified in zebrafish using the RNAi approach. This gene, named pouII-1, contains a POU domain that shares a high identity with mammalian Oct-1 and Oct-2, and its mRNA is detected in embryos at the single-cell stage and equally distributed in all blastomeres during subsequent cleavages (A. Meng, unpublished) . This gene was chosen because it should be available as a target for RNAi-induced degradation immediately upon injection of dsRNA. The first 640-bp 5Ј sequence of pouII-1, which is located outside the POU domain conserved among POU family members, was used to synthesize sense and antisense RNAs that were annealed later to form dsRNA. These three types of RNA, i.e., sense, antisense, and double-stranded RNAs, were injected separately into cytoplasm of single-cell stage embryos, initially at a dose of approximately 150 pg/e, and the embryos were observed under a dissection microscope at various stages during embryonic development. The dsRNAinjected eggs underwent normal cleavages during early development. The abnormal development of the dsRNAinjected embryos was first visible around the oblong stage when the affected embryos had a rough blastoderm surface, possibly resulting from poor attachment of adjacent cells. From the 32-cell to the oblong stages, 9.3% of the dsRNAinjected embryos died ( Fig. 2A) and 30.9% of the surviving embryos at the oblong stage were clearly affected. Some cells of the affected embryos soon detached from the blastoderm (Figs. 3A and 3B ) and the whole embryos deformed later. We found that 64.4% of the viable oblongstage embryos completely deformed at the one-somite stage and 79.7% of the survivors showed retarded growth and protruding cell masses in some areas. By 24 h postfertilization (hpf), surviving embryos accounted for only 10.7% of the total number of embryos counted at the 32-cell stage and 69.6% of the survivors showed various abnormal phenotypes. The common abnormalities at this stage included defective head, short tail, distorted midline structures, and abnormal somites (Figs. 3E and 3F ). In contrast, very few embryos injected with the sense and antisense RNA died or showed severe abnormalities during embryogenesis (Fig. 2) . When injected with the sense and antisense RNA, for example, viable embryos without abnormalities by 24 hpf accounted for 82.1 and 90.6% of the total embryos counted at the 32-cell stage, respectively. It is clear that only the dsRNA was causing the defects in embryos.
One issue to be addressed is whether the observed abnormalities in the dsRNA-injected embryos were produced by RNase One contamination in the dsRNA preparations. We injected pouII-1 dsRNA without RNase One treatment, single-stranded sense RNA treated with RNase One, and pouII-1 DNA with or without RNase One treatment. As shown in Fig. 2B , treatment with RNase One did not result in death of more embryos, indicating that dsRNA is the factor affecting the mortality of embryos.
To determine if the defects we observed were specific to pouII-1, we injected a control dsRNA synthesized using coding sequence of GFP, a reporter gene that is not present in the zebrafish genome. Unexpectedly, injection of the GFP dsRNA at a dose of 150 pg/e also induced the same types of severe defects (Figs. 3C, 3D , and 3G) and in proportions similar to those of the injected embryos as described above, whereas the development of the embryos injected with GFP single-stranded RNAs was not affected (Fig. 2A) . This can be explained in two ways: either the GFP coding sequence shares a certain homology with some developmentally important mRNAs, and these mRNAs are targeted for degradation by GFP dsRNA, or dsRNA triggers general defects in a sequence-independent manner during embryogenesis.
It has been shown that in C. elegans injection of dsRNA derived from intron and promoter sequences is unable to effectively direct sequence-specific mRNA degradation , which supports an assumption of RNAi at the posttranscriptional level . To further investigate the effect of dsRNA in zebrafish, a 650-bp sequence derived from the third intron of zebrafish terra was used to generate dsRNA (named intronT dsRNA). Zebrafish terra encodes a transcription factor and is transiently expressed in the presomitic mesoderm and newly formed somites. Overexpression of terra induces rapid apoptosis both in vitro and in vivo, suggesting that it might play a role in somite-specific apoptosis (Meng et al., 1999) . When injected with intronT dsRNA at a dose of 150 pg/e, only 11.3% of the embryos survived to 24 hpf, whereas over 90% of embryos injected with the intron-derived singlestranded RNAs remained alive at the same stage ( Fig. 2A) . Furthermore, 60% of the dsRNA-injected embryos alive at 24 hpf had defective phenotypes (Fig. 3H) , while almost all the viable embryos injected with the intron-derived singlestranded RNA appeared normal. Since about 30% of abnormal embryos had defective heads, we speculate that the observed abnormalities may not have resulted from inhibition of endogenous terra expression.
Since injections with three different types of dsRNA gave rise to similar defective phenotypes in zebrafish embryos, we conclude that dsRNA lacks gene-specific silencing activity at 150 pg/e and is very toxic to zebrafish embryos.
Toxicity of dsRNA Is Concentration-Dependent
It is possible that dsRNA can induce sequence-specific interference at lower concentrations at which general defects could be eliminated. To determine this, we injected dsRNAs of pouII-1, GFP, and terra intron at a wide range of concentrations (Fig. 4) . When the injected GFP dsRNA was reduced from 150 to 75 pg/e, the abnormal and dead embryos decreased from 96.3 to 85% as observed at 24 hpf (Fig. 4A) . This further declined to 65.5 and 48% when the dsRNA was reduced to 15 and 7.5 pg/e, respectively. At 1.5 pg/e, almost all of the injected embryos developed normally throughout the early development and embryos with some general defects at 24 hpf accounted for approximately 7%, which was similar to that when treated with the sense or antisense GFP RNA. This showed that toxicity of dsRNA on the development of embryos is concentrationdependent. We further tested pouII-1 and intronT dsRNAs and obtained results consistent with those produced by GFP dsRNA (Figs. 4B and 4C ). Since the toxicity is not sequencedependent, dsRNA must have interfered with a common process that is vital for embryonic development.
RNAi Is Incapable of Blocking Specific Gene Expression
To further test the ability of dsRNA to inhibit specific gene functions, we targeted GFP in transgenic fish using GFP dsRNA. The stable transgenic fish carry a transgene consisting of the zebrafish GATA-1 promoter and GFP cDNA (Long et al., 1997) . The expression of GFP in these transgenic fish starts at the five-somite stage and is restricted to the ventral region. Between 18 and 24 hpf, GFP is expressed in the intermediate cell mass (ICM), the early hematopoietic tissue in zebrafish. Single-cell embryos produced by mating homozygous transgenic fish to wild-type fish were injected with GFP dsRNA. As demonstrated above, very few embryos injected with a high dose of GFP dsRNA can survive to 24 hpf, a stage suitable for easy observation of GFP in transgenic embryos. Therefore, we injected the transgenic embryos with lower doses so that a sufficient number of survivors at 24 hpf could be obtained. When injected with approximately 7.5 pg/e, most of the embryos survived without obvious abnormalities at 24 hpf. All of the viable embryos (n ϭ 160) had GFP in the ICM, in a pattern identical to that of uninjected controls. After the dose of the GFP dsRNA was increased to approximately 30 pg/e, the fluorescence intensity in some of the injected embryos (n ϭ 123) was reduced. However, approximately 90% of the injected embryos that survived to 24 hpf also exhibited various embryonic defects (Figs. 5A-5D ), which resulted in an irregular GFP distribution that was difficult to observe. Injection of non-GFP dsRNA at this concentration produced similar effect (data not shown). These results suggest that GFP dsRNA is unable to inhibit GFP expression in a sequence-specific manner and that general embryonic abnormalities could obscure or reduce GFP expression. Interestingly, the concentration of GFP dsRNA used in our experiments was less than that reported by Li et al. (2000) . However, they did not find any nonspecific abnormalities in the injected embryos.
We also used a co-injection approach using the GFP reporter gene to test whether RNAi is gene-specific. GFP mRNA was co-injected with GFP, pouII-1, or intronT dsRNA into cytoplasm of fertilized eggs and the injected embryos were observed for GFP at the sphere stage. All of the embryos injected with 150 pg/e of GFP mRNA alone (n ϭ 127) had GFP expression and approximately 83% showed strong fluorescence ( Fig. 5E and Fig. 6 ). When co-injected with GFP mRNA (150 pg/e) and GFP dsRNA (75 pg/e) (n ϭ 204), only 30% of the embryos showed strong GFP expression, and the others had weak GFP expression ( Fig. 5F and Fig. 6 ). Most of the co-injected embryos showed growth arrest. Interestingly, the GFP level in the injected embryos was also reduced (Fig. 5G) when GFP mRNA was co-injected with pouII-1 (n ϭ 146) or intronT (n ϭ 117) dsRNA at 75 pg/e. This suggests that RNAi is not genespecific and inhibits general gene expression at the posttranscriptional level.
RNAi Degrades mRNA Randomly
As demonstrated above, dsRNA interferes with gene expression without sequence specificity in zebrafish. Whether the effect of dsRNA occurs at a transcriptional or a translational level needs to be determined. To address this issue, we investigated mRNA stability in the embryos injected with dsRNA by whole-mount in situ hybridization. First, embryos co-injected with GFP mRNA and GFP dsRNA or pouII-1 dsRNA, following GFP observation (detailed in the previous section), were used to perform in situ hybridization using antisense GFP probe. In comparison with the embryos injected with GFP mRNA alone, most of the embryos co-injected with GFP dsRNA showed significant reduction in GFP mRNA (Figs. 7A and 7B) . Similarly, the embryos co-injected with the unrelated dsRNA showed apparent degradation of GFP mRNA (Fig. 7C ). Then, we tested whether dsRNA could target endogenous mRNA to degrade. The dsRNA-injected embryos were subject to whole-mount in situ hybridization using the antisense pouII-1 probe. Approximately 70% of the embryos injected with 150 pg/e of either pouII-1 or GFP dsRNA showed weaker staining intensity compared to those injected with pouII-1 sense RNA. When the injection dose of the dsRNA was reduced to 30 pg/e, only about 30% of the embryos showed apparent reduction in pouII-1 mRNA. This indicates that degradation of mRNA induced by dsRNA depends on concentrations of both mRNA and dsRNA. Thus, our finding suggests that dsRNA can degrade mRNAs without sequence specificity, which might contribute to the general toxicity of dsRNA observed in zebrafish.
Studies in the past have indicated that dsRNA is toxic to cells of higher animal species because it can evoke antiviral mechanisms (Kumar and Carmichael, 1998) . Upon viral infection, dsRNA induces the synthesis of interferon (IFN) within host cells (Marcus, 1981; Lengyel, 1987) . IFN can activate a signal transduction cascade that eventually induces at least 30 genes that impede viral proliferation (Sen and Ransohoff, 1993) . The dsRNA-activated protein kinase (PKR), a serine/threonine protein kinase, is an important mediator of antiviral actions of IFN. PKR is activated by autophosphorylation upon binding to dsRNA (Galabru and Hovanessian, 1987) . The activated PKR can phosphorylate eukaryotic initiation factor 2␣ (eIF-2␣), which will sequester cellular eIF-2B, a factor required for exchange of GTP for GDP on eIF-2, to prevent translation initiation events by blocking viral and cellular protein synthesis (Kimball et al., 1996; Sarre, 1989) . Consequently, cell growth is inhibited and even programmed cell death is induced (Dever et al., 1993; Srivastava et al., 1998) . The dsRNA can also activate 2Ј,5Ј-oligoadenylate synthetase to increase 2Ј,5Ј-oligoadenylates. The 2Ј,5Ј-oligoadenylates activate the ribonuclease RNase L, which can nonspecifically degrade viral and cellular RNAs (Kerr and Brown, 1978; Player and Torence, 1998) . Castelli et al. (1997) have shown that increase of the RNase L level in mammalian cells can induce apoptosis and that inhibition of RNase L activity inhibits viral-induced apoptosis. Recently, Tuschl et al. (1999) have reported that incubation of dsRNA in the rabbit reticulocyte lysate causes rapid degradation of nonspecific mRNAs, which happens neither in wheat germ extract nor in a Drosophila cell-free system.
Our studies indicate that zebrafish eggs injected with dsRNA undergo normal cleavage but start to show visible defects at the midblastula stage. The dsRNA-injected embryos continue to exhibit global growth arrest and various defects at later developmental stages which are independent of the origin of dsRNA. We also show that dsRNA causes degradation of co-injected and endogenous mRNA regardless of sequence homology in living embryos, which is similar to what has been observed in vitro by Tuschl et al. (1999) . The toxicity we observed in zebrafish is absolutely different from what was reported by Li et al. (2000) . In their studies, embryos injected with as much as 60 pg/e dsRNA survived better than the uninjected control siblings, indicating that dsRNA is beneficial rather than toxic in zebrafish. In our experiments, we have found no evidence that dsRNA-induced genetic interference can be used as a specific means to study gene functions in the zebrafish embryos. 
